lovastatin has been researched along with Autoimmune Diabetes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
| Fang, Z; Hou, Z; Wang, F; Yang, Y; Yin, D | 1 |
| Eizyk, E; Kalén, J; Katzman, P; Nilsson, A; Sartor, G; Ugander, L; Ursing, D | 1 |
| Forsman, JA; Hirst, K; Larsen, JL; Miller, S; Stratta, RJ; Taylor, RJ | 1 |
| Parving, HH | 1 |
| Mann, JI | 1 |
| Horiuchi, Y; Maruoka, H | 1 |
| Andersen, P; Dyerberg, J; Gall, MA; Hommel, E; Jensen, B; Nielsen, F; Parving, HH; Rossing, P | 1 |
| Hagen, C; Hangaard, J; Kjaer, K; Petersen, NE | 1 |
| Edelman, S; Witztum, JL | 1 |
3 trial(s) available for lovastatin and Autoimmune Diabetes
| Article | Year |
|---|---|
Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Topics: Adult; Albuminuria; Analysis of Variance; Apolipoproteins; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Lovastatin; Male; Simvastatin; Triglycerides | 1992 |
Effect of simvastatin in patients with type I (insulin-dependent) diabetes mellitus and hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Hormones; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin | 1992 |
7 other study(ies) available for lovastatin and Autoimmune Diabetes
| Article | Year |
|---|---|
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
In situ eNOS/NO up-regulation-a simple and effective therapeutic strategy for diabetic skin ulcer.
Topics: Animals; Blood Glucose; Cell Survival; Diabetes Complications; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Carriers; Drug Liberation; Gene Expression; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Neovascularization, Physiologic; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Rats; Skin Ulcer; Tissue Scaffolds; Wound Healing | 2016 |
Gender differences in lipid alterations following combined pancreas-kidney transplantation.
Topics: Adrenergic beta-Antagonists; Adult; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Immunosuppression Therapy; Islets of Langerhans Transplantation; Kidney Transplantation; Lipids; Lovastatin; Male; Menstrual Cycle; Postoperative Period; Prolactin; Renal Insufficiency; Sex Characteristics; Triglycerides | 1994 |
Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
Topics: Anticholesteremic Agents; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lovastatin; Proteinuria; Research Design | 1996 |
The role of nutritional modifications in the prevention of macrovascular complications of diabetes.
Topics: Antioxidants; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet Therapy; Energy Intake; Energy Metabolism; Humans; Lovastatin; Minerals; Obesity; Simvastatin; Vitamins | 1997 |
Petechial eruptions due to simvastatin in a patient with diabetes mellitus and liver cirrhosis.
Topics: Anticholesteremic Agents; Biopsy, Needle; Diabetes Mellitus, Type 1; Humans; Hypercholesterolemia; Japan; Liver Cirrhosis; Lovastatin; Male; Middle Aged; Purpura; Simvastatin | 1997 |
Hyperkalemia during treatment with HMG-CoA reductase inhibitor.
Topics: Adult; Diabetes Mellitus, Type 1; Humans; Hyperkalemia; Hyperlipoproteinemia Type II; Hypertension; Kidney Diseases; Lovastatin; Male | 1989 |